Lunai Bioworks Inc. — Director's Dealing 2021

Dec 21, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Enochian Biosciences Inc (ENOB)
CIK: 0001527728
Period of Report: 2021-12-16

Reporting Person: Puche Luisa (Chief Financial Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-12-16	Restricted Stock Units	$7.75	A	16266	Acquired	2031-12-16	Common Stock (16266)	Direct
2019-06-09	Restricted Stock Units	$6.15	J	15000	Disposed	2029-06-09	Common Stock (15000)	Direct

Footnotes

F1: Each restricted stock unit represents a contingent right to receive one share of Enochian Biosciences Inc. common stock.

F2: The reporting person received restricted stock units under the Enochian BioSciences Inc. 2019 Equity Incentive Plan. 11,266 of the restricted stock units shall vest on the Grant Date; the remaining 5,000 restricted stock units shall vest on January 7, 2022. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.

F3: Reflects the decision of the Enochian BioSciences Inc. board of directors to void and rescind, nunc pro tunc, the grant of 15,000 RSUs previously approved on June 9, 2019, under the Issuer's 2019 Equity Incentive Plan. As of the date of this Form 4, 10,000 RSUs had vested; the reporting person has agreed to surrender the 10,000 shares of common stock underlying the RSUs to Enochian BioSciences Inc. for cancellation.